OMI Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

714.76M

-73.49%

0.227

-58.73%

654.27M

-75.14%

0.153

-33.35%

634.18M

-76.17%

0.198

-23.72%

Estimates Revision

The market is revising Downward the revenue expectations for Owens & Minor, Inc. (OMI) for FY2025, with the revenue forecasts being adjusted by -0.35% over the past three months. During the same period, the stock price has changed by -39.31%.

Revenue Estimates for FY2025

Revise Downward

-0.35%

In Past 3 Month

EPS Estimates for FY2025

Revise Downward

-0.2%

In Past 3 Month

Stock Price

Go Down

-39.31%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast OMI stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for OMI is 4.90 USD with a low forecast of 4.00 USD and a high forecast of 6.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

0 Buy

2 Hold

1 Sell

Moderate Sell

Current: 3.010

Low

4.00

Averages

4.90

High

6.00

Current: 3.010

Low

4.00

Averages

4.90

High

6.00

UBS

Buy

Neutral

downgrade

$7 -> $4

2025-11-03

Reason

UBS

Price Target

$7 -> $4

2025-11-03

downgrade

Buy

Neutral

Reason

UBS downgraded Owens & Minor to Neutral from Buy with a price target of $4, down from $7. The firm cites the company's limited earnings visibility and longer cash flow turnaround for the downgrade. UBS does not expect Owens & Minor's EBITDA to grow in 2026 given the Kaiser loss and higher stranded costs. The company's cash flow will not recover in the near-term given working capital constraints tied to the kitting facility, the analyst tells investors in a research note.

JPMorgan

NULL -> Underweight

downgrade

$7 -> $6

2025-08-27

Reason

JPMorgan

Price Target

$7 -> $6

2025-08-27

downgrade

NULL -> Underweight

Reason

JPMorgan lowered the firm's price target on Owens & Minor to $6 from $7 and keeps an Underweight rating on the shares. The firm updated the company's model.

UBS

Kevin Caliendo

Buy

downgrade

$13 -> $7

2025-08-13

Reason

UBS

Kevin Caliendo

Price Target

$13 -> $7

2025-08-13

downgrade

Buy

Reason

UBS analyst Kevin Caliendo lowered the firm's price target on Owens & Minor to $7 from $13 and keeps a Buy rating on the shares. Owens & Minor's Q2 results and outlook were "disappointing," the analyst tells investors in a research note. While the business is in flux, some positives remain, the firm says.

Citi

Daniel Grosslight

Buy

downgrade

$11 -> $7

2025-08-12

Reason

Citi

Daniel Grosslight

Price Target

$11 -> $7

2025-08-12

downgrade

Buy

Reason

Citi analyst Daniel Grosslight lowered the firm's price target on Owens & Minor to $7 from $11 and keeps a Buy rating on the shares. The firm says headwinds in diabetes weighed on the company's Q2 results.

BofA

Allen Lutz

Underperform

downgrade

2025-08-12

Reason

BofA

Allen Lutz

Price Target

2025-08-12

downgrade

Underperform

Reason

BofA analyst Allen Lutz lowered the firm's price target on Owens & Minor to $4.70 from $7.50 and keeps an Underperform rating on the shares. The firm, which expects O&M to divest its Product and Healthcare Services hospital distribution business in the near-term, is lowering its FY25 and FY26 revenue estimates to reflect the removal of the P&HS segment from its model starting in Q2 as well as slightly lower growth in Patient Direct.

Baird

Outperform -> NULL

downgrade

$10 -> $7

2025-08-12

Reason

Baird

Price Target

$10 -> $7

2025-08-12

downgrade

Outperform -> NULL

Reason

Baird lowered the firm's price target on Owens & Minor to $7 from $10 and keeps an Outperform rating on the shares. The firm updated its model following Q2 results.

Valuation Metrics

The current forward P/E ratio for Owens & Minor Inc (OMI.N) is 3.64, compared to its 5-year average forward P/E of 10.64. For a more detailed relative valuation and DCF analysis to assess Owens & Minor Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

10.64

Current PE

3.64

Overvalued PE

14.41

Undervalued PE

6.86

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

7.31

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

8.94

Undervalued EV/EBITDA

5.68

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.18

Current PS

0.00

Overvalued PS

0.27

Undervalued PS

0.09

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

Bought

OMI News & Events

Events Timeline

No data

News

8.0

12-05NASDAQ.COM

Are Options Traders Aware of Insights About Owens & Minor Stock That We Are Not?

1.0

12-02Newsfilter

Owens & Minor Management to Attend Two Investor Conferences

6.0

11-03Benzinga

Charter Communications Analyst Changes Stance; Check Out the Top 5 Downgrades for Monday

People Also Watch

Frequently Asked Questions

What is Owens & Minor Inc (OMI) stock price today?

The current price of OMI is 3.01 USD — it has increased 0 % in the last trading day.

What is Owens & Minor Inc (OMI)'s business?

Owens & Minor, Inc. is a global healthcare solutions company providing essential products and services that support care from the hospital to the home. The Company operates through two segments: Products & Healthcare Services and Patient Direct. The Products & Healthcare Services segment includes its United States distribution division (Medical Distribution), including an outsourced logistics and value-added services business, and its Global Products division, which manufactures and sources medical surgical products through its production and kitting operations. It provides medical supplies and solutions for infection prevention across acute, alternate site and consumer channels. The Patient Direct segment includes its home healthcare divisions (Byram and Apria). The segment provides delivery of disposable medical supplies sold directly to patients and home health agencies and is a provider of integrated home healthcare equipment and related services in the United States.

What is the price predicton of OMI Stock?

What is Owens & Minor Inc (OMI)'s revenue for the last quarter?

Owens & Minor Inc revenue for the last quarter amounts to 697.26M USD, increased 1.52 % YoY.

What is Owens & Minor Inc (OMI)'s earnings per share (EPS) for the last quarter?

Owens & Minor Inc. EPS for the last quarter amounts to -1.94 USD, increased 1041.18 % YoY.

What changes have occurred in the market's expectations for Owens & Minor Inc (OMI)'s fundamentals?

How many employees does Owens & Minor Inc (OMI). have?

Owens & Minor Inc (OMI) has 13500 emplpoyees as of December 16 2025.

What is Owens & Minor Inc (OMI) market cap?

Today OMI has the market capitalization of 232.81M USD.